Covered recipient · General Payments record
PATRICK S ZIMMERMANN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,728.67
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.18 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $46.95 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $39.14 | 2 |
| Amgen Inc. | $34.70 | 2 |
| Novo Nordisk AS | $22.61 | 1 |
| Verrica Pharmaceuticals Inc. | $20.10 | 1 |
| PFIZER INC. | $16.04 | 1 |
| Acerta Pharma LLC | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.80 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116224525 | CMS |
| Amgen Inc. | $15.90 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117726065 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.64 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104454734 | CMS |
| Lilly USA, LLC | $23.70 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135317256 | CMS |
| Lilly USA, LLC | $23.25 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135269182 | CMS |
| Novartis Pharmaceuticals Corporation | $19.00 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087426954 | CMS |
| Novartis Pharmaceuticals Corporation | $20.14 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087426962 | CMS |
| Novo Nordisk Inc | $22.61 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097287012 | CMS |
| PFIZER INC. | $16.04 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131848098 | CMS |
| Verrica Pharmaceuticals Inc. | $20.10 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118388562 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.